MedWire (4/27, Grasmo) reports, “Adolescents who use methamphetamine or methylenedioxy-methamphetamine (MDMA) are at risk for developing subsequent depressive symptoms,” according to a study published online April 19 in the Journal of Epidemiology and Community Health. After following some 3,880 Canadian secondary-school children for five years, researchers found that “both MDMA and methamphetamine use significantly increased the likelihood for having elevated depressive symptoms in the following year (odds ratio [OR]=1.7 and 1.6, respectively).” What’s more, “individuals who used both MDMA and methamphetamine, but not those who used just one of the drugs, were significantly more likely than nonusers to report elevated depressive symptoms the following year (OR=1.9).”
Related Links:
— “Methamphetamine, MDMA use increases risk for depressive symptoms,”Ingrid Grasmo , MedWire News, April 27, 2012.